Skip to main content
. 2016 Aug 25;107(9):1198–1205. doi: 10.1111/cas.12985

Figure 1.

Figure 1

Antibody‐dependent cellular cytotoxicity (ADCC) activity of rat anti–human podoplanin antibody NZ‐1 against NCI‐H290/PDPN in vitro. (a) Expression of podoplanin was detected by FACS analysis. (b) ADCC activity of NZ‐1 using rat splenocytes against NCI‐H290/PDPN or NCI‐H290/Mock was evaluated by 6‐h 51Cr release assay in the presence of antibody (1 μg/mL; effector/target [E/T] ratio 100). (c) E/T ratio‐dependent and antibody dose‐dependent effects of ADCC against NCI‐H290/PDPN mediated by NZ‐1 with rat splenocytes are shown by 51Cr release assay. (d) Rat natural killer (NK) (CD161a+) cells were isolated from rat splenocytes. ADCC activity of NZ‐1 (1 μg/mL) mediated by NK (CD161a+) cells was evaluated by 6‐h 51Cr release assay at an E/T ratio of 10. **P < 0.01 versus control (values represent mean ± SE). rIgG, rat IgG.